Old Web
English
Sign In
Acemap
>
Paper
>
FBXW7 loss identifies a subgroup of bladder cancer patients with poor prognosis who benefit from neoadjuvant chemotherapy
FBXW7 loss identifies a subgroup of bladder cancer patients with poor prognosis who benefit from neoadjuvant chemotherapy
2021
T. Matsumoto
Y Chen
Alberto Contreras-Sanz
K. Ikeda
Takeshi Sano
M. Roberts
Igor Moskalev
Peter C. Black
Keywords:
Bladder cancer
poor prognosis
Chemotherapy
Medicine
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]